Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2024
|
David J Mauro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,808
+9.89%
|
-
|
|
Feb 09
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,233
-0.29%
|
$32,330
$10.09 P/Share
|
|
Feb 09
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
344,597
+12.18%
|
-
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,272
-5.87%
|
$434,448
$9.22 P/Share
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.66%
|
$62,500
$2.48 P/Share
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.25%
|
-
|
|
Feb 07
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.23%
|
-
|
|
Feb 06
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$103,023
$9.3 P/Share
|
|
Jan 25
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.89%
|
$80,000
$10.35 P/Share
|
|
Jan 25
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.86%
|
$8,000
$1.06 P/Share
|
|
Jan 23
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.27%
|
$200,540
$10.58 P/Share
|
|
Jan 17
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.49%
|
$250,000
$10.25 P/Share
|
|
Jan 17
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.59%
|
$75,000
$2.22 P/Share
|
|
Jan 16
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.52%
|
$250,000
$10.45 P/Share
|
|
Jan 16
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.64%
|
$75,000
$2.22 P/Share
|
|
Jan 16
2024
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.63%
|
$180,000
$10.93 P/Share
|
|
Jan 16
2024
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.42%
|
$36,000
$2.22 P/Share
|
|
Jan 09
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.14%
|
$260,702
$13.51 P/Share
|
|
Jan 09
2024
|
Dean Y Li Director |
SELL
Open market or private sale
|
Indirect |
29,000
-3.23%
|
$377,000
$13.84 P/Share
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$225,000
$9.5 P/Share
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,853
-3.75%
|
$277,677
$9.49 P/Share
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.66%
|
$62,500
$2.48 P/Share
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.25%
|
-
|
|
Jan 03
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.23%
|
-
|
|
Jan 02
2024
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+0.09%
|
-
|
|
Jan 02
2024
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,393
+2.46%
|
-
|
|
Jan 02
2024
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+3.17%
|
-
|
|
Dec 28
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.89%
|
$80,000
$10.58 P/Share
|
|
Dec 28
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.86%
|
$8,000
$1.06 P/Share
|
|
Dec 26
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
20,054
-0.27%
|
$200,540
$10.63 P/Share
|
|
Dec 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.63%
|
$162,000
$9.6 P/Share
|
|
Dec 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.42%
|
$36,000
$2.22 P/Share
|
|
Dec 14
2023
|
Zavain Dar Director |
SELL
Open market or private sale
|
Direct |
20,141
-27.23%
|
$181,269
$9.0 P/Share
|
|
Dec 13
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.55%
|
$175,000
$7.59 P/Share
|
|
Dec 13
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.68%
|
$75,000
$2.22 P/Share
|
|
Dec 12
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.15%
|
$80,129
$7.4 P/Share
|
|
Dec 12
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.58%
|
$175,000
$7.39 P/Share
|
|
Dec 12
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+3.73%
|
$75,000
$2.22 P/Share
|
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
59,829
-7.03%
|
$418,803
$7.49 P/Share
|
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.54%
|
$62,500
$2.48 P/Share
|
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.21%
|
-
|
|
Dec 06
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.19%
|
-
|
|
Nov 28
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.15%
|
$68,682
$6.72 P/Share
|
|
Nov 16
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.72%
|
$18,000
$6.76 P/Share
|
|
Nov 16
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.72%
|
$3,000
$1.06 P/Share
|
|
Nov 15
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,913
-2.02%
|
$118,391
$7.18 P/Share
|
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,603
-2.57%
|
$25,221
$7.18 P/Share
|
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
18,000
-11.37%
|
$108,000
$6.51 P/Share
|
|
Nov 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+10.21%
|
$36,000
$2.22 P/Share
|